Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials

Published:2021-02-13 Issue:3 Volume:14 Page:383-397
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Cunha Karin Soares¹²,Lima Flávia³,Cardoso Roberta Marques⁴

Affiliation:

1. Postgraduate Program in Pathology, Medical School, Universidade Federal Fluminense, UFF, Niterói, Rio De Janeiro, Brazil

2. Department of Pathology, Medical School, Universidade Federal Fluminense, UFF, Niterói, Brazil

3. Private Practice, Niterói, Rio De Janeiro, Brazil

4. Specialization Course of Orofacial Harmonization, Centro Universitário Avantis/SM Odontologia, Niterói, Rio De Janeiro, Brazil

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1884070

Reference28 articles.

1. Efficacy, patient‐reported outcomes and safety profile of ATX ‐101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III , randomized, placebo‐controlled study

2. ATX-101 (deoxycholic acid injection) for reduction of submental fat

3. A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat

4. REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction

5. Reduction of unwanted submental fat with ATX ‐101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III , randomized, placebo‐controlled study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel injectable polypeptide nanoparticle encapsulated siRNA targeting TGF‐β1 and COX‐2 for localized fat reduction I: Preclinical in vitro and animal models;Journal of Cosmetic Dermatology;2024-08-21

2. PERFIL LIPÍDICO E HEPÁTICO APÓS A APLICAÇÃO DE SUBSTÂNCIAS LIPOLÍTICAS EM PROCEDIMENTO ESTÉTICO;Revista Contemporânea;2024-06-20

3. Adipocyte-targeted delivery of rosiglitazone with localized photothermal therapy for the treatment of diet-induced obesity in mice;Acta Biomaterialia;2024-06

4. Impact of Novel Teflon-DCA Nanogel Matrix on Cellular Bioactivity;Journal of Pharmaceutical Sciences;2023-03

5. Tapencarium (RZL-012) for Flank Fat Reduction: A Proof-of-Concept Study;Aesthetic Surgery Journal Open Forum;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3